Jim Cramer on Colgate-Palmolive Company (CL): Here’s Why the Once “Safe Stock” Is Facing Pressure

We recently published a list of 7 Consumer Goods and Retail Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against consumer goods and retail stocks on Jim Cramer’s radar.

Jim Cramer, host of Mad Money, recently took a close look at market trends and explained why many stocks are continuing to struggle, specifically in sectors like consumer goods. Cramer pointed out that the ongoing bear market is showing no signs of easing, with stock prices persistently declining day after day.

While Cramer acknowledged that inflation remains a concern, with the Federal Reserve continuing to highlight the issue, he encouraged investors to keep in mind the underperformance of these key sectors.

“This is a market that rewards growth regardless of price. So, people will pay up for tech growth, which is all about real demand and pricing power, and they’re avoiding companies that have lost pricing power and offer yields that are too low to compete with Treasurys. I don’t expect that dynamic to change any time soon.”

READ ALSO: Jim Cramer Talked About These 9 Nuclear Power and Quantum Computing Stocks and 10 S&P 500 Stocks on Jim Cramer’s Radar

“They spent last year hurting the market and this year already many are in the red. It’s not just a continuation people, it’s actually an acceleration.”

He also highlighted that while tech stocks related to artificial intelligence and advanced computing have helped prop up the market, many other sectors have been facing significant challenges. Cramer singled out industries such as real estate, healthcare, housing, biotech, materials, and food, sectors that underperformed dramatically last year and are showing similar weaknesses this year.

“Bottom line: When you look at these super underperforming stocks, all I can say is, maybe the Fed had better be careful for what it wishes for. Companies that represent a gigantic chunk of the real economy have seen their stocks swoon. Could their earnings be that far behind, and could inflation be running its course a lot faster than expected?”

Our Methodology

For this article, we compiled a list of 7 stocks that were discussed by Jim Cramer during the episode of Mad Money on January 6. We listed the stocks in the order that Cramer mentioned them. We also provided hedge fund sentiment for each stock as of the third quarter of 2024, which was taken from Insider Monkey’s database of 900 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Jim Cramer on Colgate (CL): Here’s Why the Once “Safe Stock” Is Facing Pressure

An array of toothpaste, toothbrushes, and mouthwashes on a bright background, highlighting the company’s oral care products.

Colgate-Palmolive Company (NYSE:CL)

Number of Hedge Fund Holders: 54

Cramer recently questioned why Colgate-Palmolive Company (NYSE:CL) stock was down recently, comparing its performance to that of dog food. He explored several potential reasons for the decline, with one of the most significant factors being rising interest rates. According to Cramer, when long-term interest rates increase, as they have since the Federal Reserve began lowering short-term rates, stocks like Colgate’s often face significant pressure.

He pointed out that while dividends are typically seen as a safety net during such times, even they haven’t been enough to protect these stocks from the negative effects of higher interest rates.

“But they become a source of vulnerability when bond yields, the main competition [of] dividend stocks, keep marching higher and they might do that all week because long rates are rising thanks to supply. The Treasury Department sold 3-year note today and the auction fell flat on its face. Tomorrow, the Treasury sells 10-year paper and Wednesday, I don’t know if the market is prepped for a 30-year paper, but there’s a ton coming. As these bonds go down in price and up in yield, things get worse and worse for the dividend stocks, even if there’s actually nothing wrong at the companies.”

Cramer pointed out that another reason for the struggles of consumer packaged goods companies is the strength of the U.S. dollar. These companies, which often have significant operations abroad, are especially impacted by a stronger dollar. Cramer explained how the stock market tends to operate, with consumer staples stocks often moving in tandem.

When the dollar negatively affects a large international company, it can create a ripple effect, bringing down other companies in the same sector, even those that may not be directly impacted. He noted that sector ETFs act like gravity, pulling down all companies within that sector, regardless of their individual performance.

“Now then there’s the most insidious problem of all, the one that no one is talking about. Let’s open the discussion, pricing.”

Cramer discussed the growing issue of pricing pressure, pointing out heavy discounts on consumer products, especially on online platforms. He highlighted the intense competition from large retailers offering low prices, which is creating challenges for businesses.

Cramer suggested that these consumer goods companies are now starting to lose that momentum. He speculated that consumers, who had accepted higher prices during the pandemic, may no longer be willing to tolerate such inflated costs from companies like Procter & Gamble and Colgate. Cramer noted that the market might be indicating that these companies will eventually need to roll back their prices.

“Now, look at this counterintuitive situation. I know it sounds crazy to call Procter & Gamble and Clorox, Colgate risky. These were safety stocks for most of my life, but there’s nothing safe about their stocks anymore.”

Colgate-Palmolive Company (NYSE:CL) is a leading global manufacturer and seller of consumer goods, known for its wide array of brands such as Colgate, Protex, Sanex, Meridol, Softlan, and Ajax. The company is facing some challenges related to its cost structure in 2024, particularly concerning raw and packaging materials. However, management expects these pressures to arise more from transactional foreign exchange impacts than from the underlying costs of commodities.

At the Morgan Stanley Global Consumer Conference in December 2024, management explained how the company approaches pricing. They adjust prices for the transactional component but avoid making significant adjustments to the translational side, as doing so could harm its competitiveness in local markets. The company takes a comprehensive view of foreign exchange impacts, especially with the recent volatility seen in Latin America.

Colgate-Palmolive (NYSE:CL) management remains confident in the company’s long-term prospects, with expectations for growth in the range of 3% to 5%, which aligns with global economic projections. Additionally, the company has struck a better balance between pricing and volume in 2024, and management expects this balance to continue moving forward.

Overall, CL ranks 2nd on our list of consumer goods and retail stocks on Jim Cramer’s radar. While we acknowledge the potential of CL as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CL but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock

Disclosure: None. This article is originally published at Insider Monkey.